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Abstract
Background: Surgical site infection (SSI) are the third most frequently reported nosocomial infection, and the most
common on surgical wards. HIV-infected patients may increase the possibility of developing SSI after surgery. There
are few reported date on incidence and the preventive measures of SSI in HIV-infected patients. This study was to
determine the incidence and the associated risk factors for SSI in HIV-infected patients. And we also explored the
preventive measures.
Methods: A retrospective study of SSI was conducted in 242 HIV-infected patients including 17 patients who
combined with hemophilia from October 2008 to September 2011 in Shanghai Public Health Clinical Center. SSI
were classified according to Centers for Disease Control and Prevention (CDC) criteria and identified by bedside
surveillance and post-discharge follow-up. Data were analyzed using SPSS 16.0 statistical software (SPSS Inc.,
Chicago, IL).
Results: The SSI incidence rate was 47.5% (115 of 242); 38.4% incisional SSIs, 5.4% deep incisional SSIs and 3.7%
organ/space SSIs. The SSI incidence rate was 37.9% in HIV-infected patients undergoing abdominal operation.
Patients undergoing abdominal surgery with lower preoperative CD4 counts were more likely to develop SSIs. The
incidence increased from 2.6% in clean wounds to 100% in dirty wounds. In the HIV-infected patients combined
with hemophilia, the mean preoperative albumin and postoperative hemoglobin were found significantly lower
than those in no-SSIs group (P<0.05).
Conclusions: SSI is frequent in HIV-infected patients. And suitable perioperative management may decrease the
SSIs incidence rate of HIV-infected patients.
Background
Surgical site infection (SSI) are the third most frequently
reported nosocomial infection, and the most common
on surgical wards [1]. The Centers for Disease and
Prevention (CDC) estimates that 22% of all the health-
care-associated infections are SSI, with an increasing
percentage over the last decennium [1,2]. SSI increase
morbidity as well as mortality, double the length of
hospital stay [3-6] and increase the cost of surgery
two-fivefold [7]. Kirkland et al. showed that 60% of the
patients who develop an SSI are more likely to be ad-
mitted to an intensive care unit (ICU), or to be hospi-
talized for another 5 days and more than five times
more likely to be re-admitted. Therefore, SSI rates are
increasingly seen as a performance indicator for the
quality of health care [8]. In 2009, the World Health
Organization issued guidelines on how to prevent SSI
in developed as well as in developing countries [9].
Human immunodeficiency virus (HIV)/acquired im-
mune deficiency syndrome (AIDS) is a worldwide pan-
demic. In recent years, the number of HIV-infected
patients is progressively increasing. The introduction of
highly active antiretroviral therapy (HAART) has signifi-
cantly improved the life expectancy of patients infected
with HIV and those diagnosed with AIDS [10-15]. The
demand for surgical treatment in HIV-infected patients
combined with surgical disease is on the rise [16,17].
The progressive failure of the immune system in patients
caused by HIV can increase the possibility of developing
surgical site infections after surgery. The aim of this
study was to determine the incidence and the associated
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risk factors for SSI in HIV-infected patients. And we also
explored the preventive measures.
Methods
Definitions
Centers for Disease Control and Prevention (CDC) def-
inition for wound class and classification of SSI were
used. Surgical site infection (SSI) was defined as an in-
fection occurring within 30 days of the operative proced-
ure, with the patient having one or more of the
followings: (i) purulent drainage from the surgical inci-
sion; (ii) organisms isolated from an aseptically obtained
culture of fluid or tissue from the surgical incision; (iii)
at least one of the following: pain or tenderness, loca-
lized swelling, redness, or heat. SSIs were classified as
being incisional, deep incisional or organ/space. A surgi-
cal procedure was defined as the single surgery that was
performed in the operating theatre. If more than two
surgical procedures were performed in a single patient,
the characteristics of the first surgical procedure were
described.
Data collection
Clinical data on HIV-infected patients undergoing sur-
gery from October 2008 to September 2011 were
retrieved using our computerized patient record system.
Inclusion criteria: HIV-infected patients were identified
and diagnosed by local Centers for the Disease Preven-
tion and Control in different places. HIV test was done
using ELISA and Western blot. Upon admission, all
selected patients had records containing information on
thorough disease histories, physical examinations, pre-
operative and postoperative routine examination, and
immune function tests.
Patient group and study methods
A retrospective study of SSI was conducted in 242 HIV-
infected patients including 17 patients who combined
with hemophilia from October 2008 to September 2011
in Shanghai Public Health Clinical Center. SSI were clas-
sified according to Centers for Disease Control and Pre-
vention (CDC) criteria and identified by bedside
surveillance and post-discharge follow-up. We stratified
and compared the incidence of SSIs according to pre-
operative CD4 counts with breakpoint values of 200 and
wound class. Patients combined with hemophilia were
divided into SSIs group (A) and no-SSIs group (B).
Demographic and clinical information was entered into
a database that included: type of surgical procedure, age,
peripheral blood cells, plasma albumin, CD4 counts, and
CD4/CD8 ratios.
Our study was a retrospective study conformed to the
tenets of the Declaration of Helsinki. It had been
approved by Institutional Ethics Review Board of
Shanghai Public Health Clinical Center (International
index IORG0006364).
Statistical analysis
Data were analyzed using SPSS 16.0 statistical software
(SPSS Inc., Chicago, IL). Results of all continuous data
are presented here as mean± standard deviation. Con-
tinuous variables were compared with independent t-test.
Univariate analysis of the categorical outcome was car-
ried out using Chi-squared tests. P<0.05 indicates statis-
tical significance.
Results
Two hundred and forty-two HIV-infected patients were
included in this study. Their mean (SD) age was
42 ± 13 years, and 220 (90.9%) were male. There were
four deaths in the study population, all of whom had
developed organ/space SSI and sever sepsis. The SSI cu-
mulative incidence rate was 47.5% (115 of 242). The in-
cidence of superficial incisional SSI was 38.4%, deep
incisional SSI was 5.4%, and organ/space SSI was 3.7%.
The types of surgical operations are listed in Table 1.
Comparisons of the incidence of SSIs according to
preoperative CD4 counts are shown in Table 2 and
Table 3. Patients with lower preoperative CD4 counts
undergoing abdominal surgery were more likely to de-
velop SSIs. In total patients, no significant differences
were seen according to preoperative CD4 counts.















Perianal Surgery 4 55 0 0 59
Purulent Drainage 2 8 6 4 20
Orthopedic Surgery 20 6 1 0 27
Lymphadenectomies 12 3 0 0 15
Partial Hepatectomy 12 2 1 1 16
Colon Surgery 8 10 1 1 20
Skin Tumor Removal 20 2 0 0 22
Amputation 0 1 1 0 2
Splenectomy 7 0 0 1 8
Thyroidectomy 9 0 0 0 9
Appendectomy 2 2 0 0 4
Gastric Surgery 3 0 0 0 3
Tumor Resection 7 0 0 1 8
Hernia 4 0 0 0 4
Urinary Operation 7 1 0 1 9
Others 10 3 3 0 16
Total 127 93 13 9 242
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Surgical procedures were classified as clean (N= 77;
31.8%), contaminated (N= 154; 63.6%) and dirty (N= 11;
4.5%). The incidence of SSI differed significantly depend-
ing on wound class, and increased from 2.6% in patients
with clean wounds to 100% in patients with dirty wound
(Table 3). Our data show that SSIs were frequent and
differed widely by wound class.
Patients combined with hemophilia were divided into
SSIs group (A) and no-SSIs group (B). Comparisons of
clinical date between two groups are given in Table 4. In
the SSIs group, the mean preoperative albumin and
postoperative hemoglobin were found significantly lower
than those in no-SSIs group (P<0.05). Other laboratory
variables were not seen different between two groups
(P>0.05).
Discussion
The progressive failure of the immune system in patients
caused by HIV can increase the possibility of developing
surgical site infections after surgery. Our study demon-
strated an incidence of 47.5% SSIs in HIV-infected
patients. This number is above the average SSI rate of
2.61% by the NNIS review [18]. Drapeau CM et al.
showed the SSI rate of HIV-infected patients was two-
fold than that reported in Italian and European studies
for general population [19]. In abdominal operations,
patients’ mean preoperative CD4 counts in the SSIs
group were found significantly lower than those in no-
SSIs group, suggesting it may be associated with SSIs.
Mawalla et al. also observed the rate of SSI among HIV
patients was significantly higher with CD4 count below
200 cell/μ L[20]. It is universally accepted that the CD4
counts is a valuable marker of disease progression in
HIV and AIDS. Generally, when CD4 counts >350cells/
μ L, there is no obvious damage to the immune func-
tion, patients’ treatment and range of indications for sur-
gery can be same as normal surgical patients without
HIV infected; when CD4 counts is between 200–350
cells/μ L, patients need to examine body completely to
find whether merge other complications and start highly
active anti-retrovirus therapy (HAART). And for those
patients whose preoperative CD4 counts ≤ 200 cells/μ L,
the antibiotic and antifungal medications (sulfamethoxa-
zole/trimethoprim (SMZ/TMP) and fluconazole) are
started preoperatively as prophylaxis against Pneumocys-
tis carinii pneumonia (PCP) and fungal infection.
In our opinion, the evaluation of the risk of developing
SSIs for HIV-infected patients should be an integral part
of the perioperative management. Although the
optimum time for surgery still needs clarification in fur-
ther studies, it may be better to delay elective surgery
until the preoperative CD4 count>200cells/μ L. How-
ever, in patients with typically surgical problems, e.g., ap-
pendicitis and gastrointestinal perforation, early surgery
allows for rapid recovery similar to normal surgical
patients irrespective of CD4 count.
Our data show that SSIs were frequent and differed
widely by wound class. Wound care efore operations for
contaminated and dirty wounds should be done with
more caution. Further strengthening of basic infection
control in the hospital to improve the hospital environ-
ment is also required. Another important intervention
will be required to encourage surgeons to use
Table 2 Incidence of SSIs in patients undergoing
abdominal surgery stratified by preoperative CD4 counts





<200 16(64%) 14(34.1%) 1
≥200 9(36%) 27(65.9%) 0.02 0.292 0.103-0.826
Table 3 Comparisons of the Incidence of SSIs in all
patients




<200 47(46.5%) 47(42.7%) 1
≥200 54(53.5%) 63(57.3%) 0.087 0.796 0.739-0.857
Wound class
Clean 2(1.7%) 75(59.1%) 1
Contaminated 102(88.7%) 52(40.9%) <0.001 71.87 16.96-304.48
Dirty 11(9.6%) 0 <0.001 76.71 18.24-322.68
Table 4 Comparison of Clinical Data between Group A
and Group B
Parameters Group A Group B t P
Preoperative
CD4 (cell/μ l) 382.1 ± 184.1 382.0 ± 111.3 −0.002 0.999
CD8 (cell/μ l) 609.4 ± 362.9 743.0 ± 318.9 0.717 0.487
CD4/CD8 0.7476 ± 0.361 0.6012 ± 0.295 −0.809 0.434
WBC(x109/L) 6.51 ± 2.79 4.72 ± 1.53 −1.521 0.151
Hemoglobin (g/L) 123.7 ± 25.5 142.7 ± 31.1 1.344 0.200
Platelet(x109/L) 176.5 ± 120.1 267 ± 131.7 1.435 0.173
Albumin (g/L)* 39.9 ± 5.2 46.7 ± 1.3 3.792 0.004
Postoperative
CD4 (cell/μl) 382.6 ± 186.1 388.4 ± 91.4 0.063 0.952
CD8 (cell/μl) 498.6 ± 67.3 723 ± 358.4 1.376 0.206
CD4/CD8 0.766± 0.355 0.652 ± 0.329 −0.527 0.613
WBC(x109/L) 7.895 ± 4.668 5.84 ± 1.92 −1.143 0.281
Hemoglobin (g/L)* 103.4 ± 24.5 134.8 ± 27.2 2.354 0.035
Platelet(x109/L) 169.1 ± 48.5 226.3 ± 133.7 1.071 0.318
Albumin (g/L) 40.0 ± 5.5 43.9 ± 3.3 1.657 0.122
Group A= SSI; Group B = no-SSI; WBC=white blood cell.
*Statistical significance.
Zhang et al. BMC Infectious Diseases 2012, 12:115 Page 3 of 4
http://www.biomedcentral.com/1471-2334/12/115
appropriate antibiotic prophylaxis. Petrosillo N et al.
found that antibiotic prophylaxis was also associated
with postdischarge SSI [21].
In the HIV-infected patients combined with
hemophilia, there was a clinically significant decrease of
postoperative hemoglobin count in the SSIs group com-
pared with the no-SSIs group, which is mainly associated
with SSIs. Bleeding is the major risk of intraoperation
and postoperation for hemophilia . Infusing 2000 units of
factor VII 2 times one day before surgery, 2000 units of
factor VII 2 hours before operation, 2000–4000 units
during operation, can improve patients’ coagulation to
normal levels.
One of the limitations of the study was information
biases due to the retrospective nature of the design
study. The other was that it did not control for possible
confounders other than those investigated.
Conclusions
Postoperative SSIs are frequent in HIV-infected patients.
It appears necessary to establish a reliable and efficient
national monitoring programme for the implementation
of preventive measures.
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